Clinical Implication of Hypoxic Liver Injury for Predicting Hypoxic Hepatitis and In-Hospital Mortality in ST Elevation Myocardial Infarction Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: In this study, we aimed to determine the value of hypoxic liver injury (HLI) in the emergency room (ER) for predicting hypoxic hepatitis (HH) and in-hospital mortality in ST elevation myocardial infarction (STEMI) patients. Materials and Methods: 1537 consecutive STEMI patients were enrolled. HLI in the ER was defined as a ≥2-fold increase in serum aspartate transaminase (AST). HH was defined as a ≥20-fold increase in peak serum transaminase. Patients were divided into four groups according to HLI and HH status (group 1, no HLI or HH; group 2, HLI, but no HH; group 3, no HLI, but HH; group 4, both HLI and HH). Results: The incidences of HLI and HH in the ER were 22% and 2%, respectively. In-hospital mortality rates were 3.1%, 11.8%, 28.6%, and 47.1% for groups 1, 2, 3, and 4, respectively. Patients with HLI and/or HH had worse Killip class, higher cardiac biomarker elevations, and lower left ventricular ejection fraction. Multivariate logistic regression analysis showed that HLI in the ER was an independent predictor of HH [odds ratio 2.572, 95% confidence interval (CI) 1.166–5.675, p=0.019]. The predictive value of HLI in the ER for the development of HH during hospitalization was favorable [area under the curve (AUC) 0.737, 95% CI 0.643–0.830, sensitivity 0.548, specificity 0.805, for cut-off value AST >80]. Furthermore, in terms of in-hospital mortality, predictive values of HLI in the ER and HH during hospitalization were comparable (AUC 0.701 for HLI at ER and AUC 0.674 for HH). Conclusion: Among STEMI patients, HLI in the ER is a significant predictor for the development of HH and mortality during hospitalization (INTERSTELLAR ClinicalTrials.gov number, NCT02800421).
Abstract
Purpose: In this study, we aimed to determine the value of hypoxic liver injury (HLI) in the emergency room (ER) for predicting hypoxic hepatitis (HH) and in-hospital mortality in ST elevation myocardial infarction (STEMI) patients. Materials and Methods: 1537 consecutive STEMI patients were enrolled. HLI in the ER was defined as a ≥2-fold increase in serum aspartate transaminase (AST). HH was defined as a ≥20-fold increase in peak serum transaminase. Patients were divided into four groups according to HLI and HH status (group 1, no HLI or HH; group 2, HLI, but no HH; group 3, no HLI, but HH; group 4, both HLI and HH). Results: The incidences of HLI and HH in the ER were 22% and 2%, respectively. In-hospital mortality rates were 3.1%, 11.8%, 28.6%, and 47.1% for groups 1, 2, 3, and 4, respectively. Patients with HLI and/or HH had worse Killip class, higher cardiac biomarker elevations, and lower left ventricular ejection fraction. Multivariate logistic regression analysis showed that HLI in the ER was an independent predictor of HH [odds ratio 2.572, 95% confidence interval (CI) 1.166–5.675, p=0.019]. The predictive value of HLI in the ER for the development of HH during hospitalization was favorable [area under the curve (AUC) 0.737, 95% CI 0.643–0.830, sensitivity 0.548, specificity 0.805, for cut-off value AST >80]. Furthermore, in terms of in-hospital mortality, predictive values of HLI in the ER and HH during hospitalization were comparable (AUC 0.701 for HLI at ER and AUC 0.674 for HH). Conclusion: Among STEMI patients, HLI in the ER is a significant predictor for the development of HH and mortality during hospitalization (INTERSTELLAR ClinicalTrials.gov number, NCT02800421).
참고문헌 (24)
- Kostis WJ, "Trends in mortality of acute myocardial infarction after discharge from the hospital", Circ Cardiovasc Qual Outcomes, 3, pp.581~589 (2010)
- Morrow DA, "TIMI risk score for ST-elevation myocardial infarction : a convenient, bedside, clinical score for risk assessment at presentation : an intravenous nPA for treatment of infarcting myocardium early II trial substudy", Circulation, 102, pp.2031~2037 (2000)
- Goldberg RJ, "Thirtyyear trends(1975 to 2005)in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction : a population-based perspective", Circulation, 119, pp.1211~1219 (2009)
- Mamas MA, "Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention : insights from the British Cardiovascular Intervention Society", Eur Heart J, 35, pp.3004~3012 (2014)
- Rashed KA, "Ischaemic hepatitis in the elderly", Gerontology, 48, pp.245~249 (2002)
- Chávez-Tapia NC, "Hypoxic hepatitis in cardiac intensive care unit : a study of cardiovascular risk factors, clinical course, and outcomes", Ther Clin Risk Manag, 10, pp.139~145 (2014)
- Lofthus DM, "Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction", Coron Artery Dis, 23, pp.22~30 (2012)
- Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardioThoracic Surgery (EACTS), "Guidelines on myocardial revascularization", Eur Heart J, 31, pp.2501~2555 (2010)
- Kim TH, "Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients with acute coronary syndrome", Int J Cardiol, 177, pp.907~911 (2014)
- Moon J, "Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention", Int J Cardiol, 177, pp.442~447 (2014)
- Henrion J, "Hypoxic hepatitis in patients with cardiac failure : incidence in a coronary care unit and measurement of hepatic blood flow", J Hepatol, 21, pp.696~703 (1994)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves : a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Lim HS, "Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock", JACC Cardiovasc Interv, 2, pp.146~152 (2009)
- Tsai TT, "Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions : insights from the NCDR Cath-PCI registry", JACC Cardiovasc Interv, 7, pp.1~9 (2014)
- Kosiborod M, "Glucometrics in patients hospitalized with acute myocardial infarction : defining the optimal outcomes-based measure of risk", Circulation, 117, pp.1018~1027 (2008)
- Wróblewski F, "Serum lactic dehydrogenase activity in acute transmural myocardial infarction", Science, 123, pp.1122~1123 (1956)
- Naschitz JE, "Heart diseases affecting the liver and liver diseases affecting the heart", Am Heart J, 140, pp.111~120 (2000)
- Kavoliuniene A, "Congestive hepatopathy and hypoxic hepatitis in heart failure : a cardiologist’s point of view", Int J Cardiol, 166, pp.554~558 (2013)
- Park SD, "Prognostic impact of combined contrast-induced acute kidney injury and hypoxic liver injury in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention : results from INTERSTELLAR registry", PLoS One, 11, pp.e0159416~ (2016)
- Jang HJ, "Prognostic impact of combined dysglycemia and hypoxic liver injury on admission in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention(from the INTERSTELLAR cohort)", Am J Cardiol, 119, pp.1179~1185 (2017)
- Oh PC, "Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention", PLoS One, 15, pp.e0233286~ (2020)
- Birrer R, "Hypoxic hepatopathy : pathophysiology and prognosis", Intern Med, 46, pp.1063~1070 (2007)
- Arcidi JM Jr, "Hepatic morphology in cardiac dysfunction : a clinicopathologic study of 1000 subjects at autopsy", Am J Pathol, 104, pp.159~166 (1981)
- Ebert EC, "Hypoxic liver injury", Mayo Clin Proc, 81, pp.1232~1236 (2006)